Overview
Yu Fujita practices in Minato, Japan. Fujita is rated as a Distinguished expert by MediFind in the treatment of Lactate Dehydrogenase Deficiency. Their top areas of expertise are Lactate Dehydrogenase Deficiency, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 55 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Lactate Dehydrogenase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lactate Dehydrogenase DeficiencyFujita isDistinguished. Learn about Lactate Dehydrogenase Deficiency.
- Advanced
- Chronic Obstructive Pulmonary Disease (COPD)
- Idiopathic Pulmonary Fibrosis
- Lung CancerFujita isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Pulmonary FibrosisFujita isAdvanced. Learn about Pulmonary Fibrosis.
- Experienced
- Acute Interstitial PneumoniaFujita isExperienced. Learn about Acute Interstitial Pneumonia.
- Interstitial Lung DiseaseFujita isExperienced. Learn about Interstitial Lung Disease.
- Muscle AtrophyFujita isExperienced. Learn about Muscle Atrophy.
- PneumoniaFujita isExperienced. Learn about Pneumonia.